Desonide NDC 80425-0371

NDC codes

FDA NDC Directory

Product NDC (as listed)80425-0371Labeler and product segments. Claims need a package NDC.

Product NDC at billing width80425-0371Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
80425-0371-1	80425037101	1 TUBE in 1 CARTON (80425-0371-1) / 60 g in 1 TUBEMarketed from Dec 7, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Desonide
Generic name (nonproprietary): desonide
Active ingredients: Desonide — .5 mg/g
Dosage form: Cream
Route: Topical
Labeler: Advanced Rx of Tennessee, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210198
Marketing start: Dec 7, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 80425-0371_2a999573-102d-813a-e063-6294a90a49b1SPL ID 2a999573-102d-813a-e063-6294a90a49b1SPL set ID 0beda157-efd4-5245-e063-6394a90a6911RxCUI 349351UNII J280872D1O
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N480425037101 followed by a unit qualifier and the quantity

Package 80425-0371-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 31, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Desonide cream, 0.05% is a low potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. It should not be used for longer than two weeks unless directed by a physician.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 210198

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210198
Product	Strength	Form · route	Labeler	Product NDC
Desonide	Desonide .5 mg/g	CreamTopical	Bryant Ranch Prepack	63629-2506
Desonide	Desonide .5 mg/g	CreamTopical	Bryant Ranch Prepack	63629-2507
Desonide	Desonide .5 mg/g	CreamTopical	Viona Pharmaceuticals Inc	72578-086
Desonide	Desonide .5 mg/g	CreamTopical	Zydus Lifesciences Limited	70771-1381
Desonide	Desonide .5 mg/g	CreamTopical	Bryant Ranch Prepack	72162-2005